DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ferolla P. et al.
Shortened interval of long-acting octreotide administration is effective in patients with well-differenziated neuroendocrine carcinomas in progression on standard doses.
J Endocrinol Invest 2012;
35: 326-331
Access:
We do not assume any responsibility for the contents of the web pages of other providers.